Sintilimab Plus Rituximab Followed by R-CHOP Regimen in Untreated PMBL
Sintilimab Plus Rituximab Followed by R-CHOP Regimen in Untreated PMBL
Recruiting · NCT06742502 · Registry updated 2025-06-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Sintilimab Plus Rituximab Followed by R-CHOP Regimen in Untreated PMBL | Primary Mediastinal Diffuse Large B-cell Lymphoma | Recruiting | Phase 2 | 2025-06-05 | NCT06742502 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sun Yat-sen University | 606 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fujian Cancer Hospital | Fuzhou | China | 109 |
| Sun yat-sen university cancer cencer | Guangzhou | China | 1 |